drugset / Trial / NCT00614601
Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To assess the response for subjects with pancreatic cancer that have undergone surgical resection and treatment with a vaccine given with or without chemotherapy and chemoradiation.
Timeline
- Start
- 2008-01
- Primary completion
- 2010-05
- Completion
- 2014-12
Outcome
Outcome not reported
Stopped: “Sponsor proceeded with a phase III study for same indication.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Algenpantucel-L | Vaccine | 1e+08 cells | Other |